{"pmid":32314551,"title":"Transplant programmes during COVID-19: Unintended consequences for health inequality.","text":["Transplant programmes during COVID-19: Unintended consequences for health inequality.","Transplant programmes are being scaled back as healthcare systems worldwide respond to COVID-19. Most centres are now taking only super urgent and urgent cases, if at all. Management of donor organs is also impacted. Contingency protocols may prioritise distance over equitable sharing principles. Live and deceased donation is either being selectively paused or operating under stringent criteria based on local capacity. This will inevitably lead to variable patient experience.","Am J Transplant","Sharma, Shivani","Lawrence, Christopher","Giovinazzo, Franceso","32314551"],"abstract":["Transplant programmes are being scaled back as healthcare systems worldwide respond to COVID-19. Most centres are now taking only super urgent and urgent cases, if at all. Management of donor organs is also impacted. Contingency protocols may prioritise distance over equitable sharing principles. Live and deceased donation is either being selectively paused or operating under stringent criteria based on local capacity. This will inevitably lead to variable patient experience."],"journal":"Am J Transplant","authors":["Sharma, Shivani","Lawrence, Christopher","Giovinazzo, Franceso"],"date":"2020-04-22T11:00:00Z","year":2020,"_id":"32314551","week":"202017|Apr 20 - Apr 26","doi":"10.1111/ajt.15931","source":"PubMed","topics":["Prevention"],"weight":1,"_version_":1664714520156700672,"score":8.518259,"similar":[{"pmid":32323460,"title":"Solid Organ Transplantation Programs Facing Lack of Empiric Evidence in the COVID-19 Pandemic: A By-proxy Society Recommendation Consensus Approach.","text":["Solid Organ Transplantation Programs Facing Lack of Empiric Evidence in the COVID-19 Pandemic: A By-proxy Society Recommendation Consensus Approach.","The ongoing SARS-CoV-2 pandemic has a drastic impact on national healthcare systems. Given the overwhelming demand of facility capacity, the impact on all healthcare sectors has to be addressed. Solid organ transplantation represents a field with a high demand on staff, intensive care units and follow-up facilities. The great therapeutic value of organ transplantation has to be weighed against mandatory constraints of healthcare capacities. In addition, the management of immunosuppressed recipients has to be reassessed during the ongoing COVID-19 pandemic. In addressing these crucial questions, transplant physicians are facing a total lack of scientific evidence. Therefore, the aim of this study was to offer an approach of consensus-based guidance, derived from individual information of 22 transplant societies. Key recommendations were extracted and the degree of consensus among different organizations was calculated. A high degree of consensus was found for temporarily suspending non-urgent transplant procedures and living donation programs. Systematic PCR-based testing of donors and recipients was broadly recommended. Additionally, more specific aspects (e.g., screening of surgical explant teams and restricted use of marginal donor organs) were included in our analysis. This study offers a novel approach on informed guidance for healthcare management when a priori no scientific evidence is available.","Am J Transplant","Ritschl, Paul Viktor","Nevermann, Nora","Wiering, Leke","Wu, Helen Hairun","Morodor, Philipp","Brandl, Andreas","Hillebrandt, Karl","Tacke, Frank","Friedersdorff, Frank","Schlomm, Thorsten","Schoning, Wenzel","Ollinger, Robert","Schmelzle, Moritz","Pratschke, Johann","32323460"],"abstract":["The ongoing SARS-CoV-2 pandemic has a drastic impact on national healthcare systems. Given the overwhelming demand of facility capacity, the impact on all healthcare sectors has to be addressed. Solid organ transplantation represents a field with a high demand on staff, intensive care units and follow-up facilities. The great therapeutic value of organ transplantation has to be weighed against mandatory constraints of healthcare capacities. In addition, the management of immunosuppressed recipients has to be reassessed during the ongoing COVID-19 pandemic. In addressing these crucial questions, transplant physicians are facing a total lack of scientific evidence. Therefore, the aim of this study was to offer an approach of consensus-based guidance, derived from individual information of 22 transplant societies. Key recommendations were extracted and the degree of consensus among different organizations was calculated. A high degree of consensus was found for temporarily suspending non-urgent transplant procedures and living donation programs. Systematic PCR-based testing of donors and recipients was broadly recommended. Additionally, more specific aspects (e.g., screening of surgical explant teams and restricted use of marginal donor organs) were included in our analysis. This study offers a novel approach on informed guidance for healthcare management when a priori no scientific evidence is available."],"journal":"Am J Transplant","authors":["Ritschl, Paul Viktor","Nevermann, Nora","Wiering, Leke","Wu, Helen Hairun","Morodor, Philipp","Brandl, Andreas","Hillebrandt, Karl","Tacke, Frank","Friedersdorff, Frank","Schlomm, Thorsten","Schoning, Wenzel","Ollinger, Robert","Schmelzle, Moritz","Pratschke, Johann"],"date":"2020-04-24T11:00:00Z","year":2020,"_id":"32323460","week":"202017|Apr 20 - Apr 26","doi":"10.1111/ajt.15933","source":"PubMed","topics":["Prevention"],"weight":1,"_version_":1664895932844474368,"score":208.68},{"pmid":32282982,"title":"Early Impact of COVID-19 on Transplant Center Practices and Policies in the United States.","text":["Early Impact of COVID-19 on Transplant Center Practices and Policies in the United States.","COVID-19 is a novel, rapidly-changing pandemic: consequently, evidence-based recommendations in solid organ transplantation (SOT) remain challenging and unclear. To understand the impact on transplant activity across the US, and center-level variation in testing, clinical practice, and policies, we conducted a national survey between March 24-31, 2020 and linked responses to the COVID-19 incidence map. Response rate was a very high 79.3%, reflecting a strong national priority to better understand COVID-19. Complete suspension of live donor kidney transplantation was reported by 71.8% and live donor liver by 67.7%. While complete suspension of deceased donor transplantation was less frequent, some restrictions to deceased donor kidney transplantation were reported by 84.0% and deceased donor liver by 73.3%; more stringent restrictions were associated with higher regional incidence of COVID-19. Shortage of COVID-19 tests was reported by 42.5%. Respondents reported a total of 148 COVID-19 recipients from <1y to >10y post-transplant: 69.6% were kidney recipients, and 25.0% were critically ill. Hydroxychloroquine (HCQ) was used by 78.1% of respondents; azithromycin by 46.9%; tocilizumab by 31.3%, and remdesivir by 25.0%. There is wide heterogeneity in center-level response across the US; ongoing national data collection, expert discussion, and clinical studies are critical to informing evidence-based practices.","Am J Transplant","Boyarsky, Brian J","Chiang, Teresa Po-Yu","Werbel, William A","Durand, Christine M","Avery, Robin K","Getsin, Samantha N","Jackson, Kyle R","Kernodle, Amber B","Van Pilsum Rasmussen, Sarah E","Massie, Allan B","Segev, Dorry L","Garonzik-Wang, Jacqueline M","32282982"],"abstract":["COVID-19 is a novel, rapidly-changing pandemic: consequently, evidence-based recommendations in solid organ transplantation (SOT) remain challenging and unclear. To understand the impact on transplant activity across the US, and center-level variation in testing, clinical practice, and policies, we conducted a national survey between March 24-31, 2020 and linked responses to the COVID-19 incidence map. Response rate was a very high 79.3%, reflecting a strong national priority to better understand COVID-19. Complete suspension of live donor kidney transplantation was reported by 71.8% and live donor liver by 67.7%. While complete suspension of deceased donor transplantation was less frequent, some restrictions to deceased donor kidney transplantation were reported by 84.0% and deceased donor liver by 73.3%; more stringent restrictions were associated with higher regional incidence of COVID-19. Shortage of COVID-19 tests was reported by 42.5%. Respondents reported a total of 148 COVID-19 recipients from <1y to >10y post-transplant: 69.6% were kidney recipients, and 25.0% were critically ill. Hydroxychloroquine (HCQ) was used by 78.1% of respondents; azithromycin by 46.9%; tocilizumab by 31.3%, and remdesivir by 25.0%. There is wide heterogeneity in center-level response across the US; ongoing national data collection, expert discussion, and clinical studies are critical to informing evidence-based practices."],"journal":"Am J Transplant","authors":["Boyarsky, Brian J","Chiang, Teresa Po-Yu","Werbel, William A","Durand, Christine M","Avery, Robin K","Getsin, Samantha N","Jackson, Kyle R","Kernodle, Amber B","Van Pilsum Rasmussen, Sarah E","Massie, Allan B","Segev, Dorry L","Garonzik-Wang, Jacqueline M"],"date":"2020-04-14T11:00:00Z","year":2020,"_id":"32282982","week":"202016|Apr 13 - Apr 19","doi":"10.1111/ajt.15915","keywords":["clinical decision-making","epidemiology","guidelines","infectious agents - viral"],"source":"PubMed","topics":["Prevention"],"weight":1,"locations":["US","US","United States"],"countries":["United States"],"countries_codes":["USA|United States"],"e_drugs":["tocilizumab","remdesivir","Azithromycin","Hydroxychloroquine"],"_version_":1664636704083935233,"score":205.1243},{"pmid":32270388,"title":"Liver transplantation and COVID-19 (Coronavirus) infection: guidelines of the liver transplant Society of India (LTSI).","text":["Liver transplantation and COVID-19 (Coronavirus) infection: guidelines of the liver transplant Society of India (LTSI).","The Liver Transplant Society of India (LTSI) has come up with guidelines for transplant centres across the country to deal with liver transplantation during this evolving pandemic of COVID-19 infection. The guidelines are applicable to both deceased donor as well as living donor liver transplants. In view of the rapidly changing situation of COVID-19 infection in India and worldwide, these guidelines will need to be updated according to the emerging data.","Hepatol Int","Saigal, Sanjiv","Gupta, Subash","Sudhindran, S","Goyal, Neerav","Rastogi, Amit","Jacob, Mathew","Raja, Kaiser","Ramamurthy, Anand","Asthana, Sonal","Dhiman, R K","Singh, Balbir","Perumalla, Rajasekhar","Malik, Ashish","Shanmugham, Naresh","Soin, Arvinder Singh","32270388"],"abstract":["The Liver Transplant Society of India (LTSI) has come up with guidelines for transplant centres across the country to deal with liver transplantation during this evolving pandemic of COVID-19 infection. The guidelines are applicable to both deceased donor as well as living donor liver transplants. In view of the rapidly changing situation of COVID-19 infection in India and worldwide, these guidelines will need to be updated according to the emerging data."],"journal":"Hepatol Int","authors":["Saigal, Sanjiv","Gupta, Subash","Sudhindran, S","Goyal, Neerav","Rastogi, Amit","Jacob, Mathew","Raja, Kaiser","Ramamurthy, Anand","Asthana, Sonal","Dhiman, R K","Singh, Balbir","Perumalla, Rajasekhar","Malik, Ashish","Shanmugham, Naresh","Soin, Arvinder Singh"],"date":"2020-04-10T11:00:00Z","year":2020,"_id":"32270388","week":"202015|Apr 06 - Apr 12","doi":"10.1007/s12072-020-10041-1","source":"PubMed","topics":["Prevention"],"weight":1,"locations":["India"],"countries":["India"],"countries_codes":["IND|India"],"_version_":1664637315663790080,"score":203.78156},{"pmid":32243677,"title":"The COVID-19 outbreak in Italy: Initial implications for organ transplantation programs.","text":["The COVID-19 outbreak in Italy: Initial implications for organ transplantation programs.","The spread of Coronavirus Disease 2019 (COVID-19) has already reached a pandemic dimension within a few weeks. Italy has been one of the first countries dealing with the outbreak of COVID-19, and severe measures have been adopted to limit viral transmission. The spread of COVID-19 may have several implications in organ transplant activity that physicians should be aware of. The initial experience gained during the COVID-19 outbreak shows that around 10% of infected patients in Italy need intensive care management to overcome the acute respiratory distress syndrome. Due to the exponential rise of infected patients we are now facing an actual risk of saturation of intensive care unit (ICU) beds. A restriction in the number of ICU beds available for both donors and transplant recipients may unfavorably influence the overall donation activity, and eventually lead to a reduced number of transplants. Preliminary Italian data show that a 25% reduction of procured organs has already occurred during the first 4 weeks of COVID-19 outbreak. This underlines the need to closely monitor what will be further happening in ICUs due to the COVID-19 spread in the attempt to preserve transplant activity, especially in Western countries where deceased donors represent the major organ resource.","Am J Transplant","Angelico, Roberta","Trapani, Silvia","Manzia, Tommaso Maria","Lombardini, Letizia","Tisone, Giuseppe","Cardillo, Massimo","32243677"],"abstract":["The spread of Coronavirus Disease 2019 (COVID-19) has already reached a pandemic dimension within a few weeks. Italy has been one of the first countries dealing with the outbreak of COVID-19, and severe measures have been adopted to limit viral transmission. The spread of COVID-19 may have several implications in organ transplant activity that physicians should be aware of. The initial experience gained during the COVID-19 outbreak shows that around 10% of infected patients in Italy need intensive care management to overcome the acute respiratory distress syndrome. Due to the exponential rise of infected patients we are now facing an actual risk of saturation of intensive care unit (ICU) beds. A restriction in the number of ICU beds available for both donors and transplant recipients may unfavorably influence the overall donation activity, and eventually lead to a reduced number of transplants. Preliminary Italian data show that a 25% reduction of procured organs has already occurred during the first 4 weeks of COVID-19 outbreak. This underlines the need to closely monitor what will be further happening in ICUs due to the COVID-19 spread in the attempt to preserve transplant activity, especially in Western countries where deceased donors represent the major organ resource."],"journal":"Am J Transplant","authors":["Angelico, Roberta","Trapani, Silvia","Manzia, Tommaso Maria","Lombardini, Letizia","Tisone, Giuseppe","Cardillo, Massimo"],"date":"2020-04-04T11:00:00Z","year":2020,"_id":"32243677","week":"202014|Mar 30 - Apr 05","doi":"10.1111/ajt.15904","keywords":["critical care/intensive care management","donors and donation: donor-derived infections","editorial/personal viewpoint","epidemiology","health services and outcomes research","infection and infectious agents - viral","infectious disease","organ procurement and allocation","organ procurement organization","organ transplantation in general"],"source":"PubMed","topics":["Prevention"],"weight":1,"locations":["Italy","Italy","Italian","Italy"],"countries":["Italy"],"countries_codes":["ITA|Italy"],"_version_":1664638249342074880,"score":185.07454},{"pmid":32330351,"title":"The impact of the COVID-19 outbreak on Liver Transplantation programmes in Northern Italy.","text":["The impact of the COVID-19 outbreak on Liver Transplantation programmes in Northern Italy.","In January 2020, Novel Coronavirus Disease 2019 (COVID-19) resulted in a global pandemic, creating uncertainty towards the management of Liver Transplantation (LT) programmes. Lombardy has been the most affected region in Italy: The current mortality rate of COVID-19 patients is 18,3% (10022 deaths) (April 10th) with hospitals in Lombardy having to expand the total number of ICU beds from 724 to 1381 to accommodate infected patients. There has been a drastic decrease in liver donors. From February 23(rd) until April 10th, 17 LTs were performed in Lombardy. Mean donor age was 49 years (range 18-74) whereas mean recipient age was 55 (13-69); mean MELD Score was 12 (6-24). All donors underwent screening for SARS CoV-2 prior to LT. Two patients tested positive after LT, and one patient died for COVID on POD 30. 16 patients are alive after an average of 30 days post LT (range 3-46). 10 patients have been discharged. This study has found no specific reason concerning the safety of recipients, to stop liver transplantation programmes. Several Key-lessons from our experience are reported. However, due to the complex circumstances which surround the viral outbreak, the cessation or a reduction in LT activity is a pragmatic requirement.","Am J Transplant","Maggi, Umberto","De Carlis, Luciano","Yiu, Daniel","Colledan, Michele","Regalia, Enrico","Rossi, Giorgio","Angrisani, Marco","Consonni, Dario","Fornoni, Gianluca","Piccolo, Giuseppe","DeFeo, Tullia Maria","32330351"],"abstract":["In January 2020, Novel Coronavirus Disease 2019 (COVID-19) resulted in a global pandemic, creating uncertainty towards the management of Liver Transplantation (LT) programmes. Lombardy has been the most affected region in Italy: The current mortality rate of COVID-19 patients is 18,3% (10022 deaths) (April 10th) with hospitals in Lombardy having to expand the total number of ICU beds from 724 to 1381 to accommodate infected patients. There has been a drastic decrease in liver donors. From February 23(rd) until April 10th, 17 LTs were performed in Lombardy. Mean donor age was 49 years (range 18-74) whereas mean recipient age was 55 (13-69); mean MELD Score was 12 (6-24). All donors underwent screening for SARS CoV-2 prior to LT. Two patients tested positive after LT, and one patient died for COVID on POD 30. 16 patients are alive after an average of 30 days post LT (range 3-46). 10 patients have been discharged. This study has found no specific reason concerning the safety of recipients, to stop liver transplantation programmes. Several Key-lessons from our experience are reported. However, due to the complex circumstances which surround the viral outbreak, the cessation or a reduction in LT activity is a pragmatic requirement."],"journal":"Am J Transplant","authors":["Maggi, Umberto","De Carlis, Luciano","Yiu, Daniel","Colledan, Michele","Regalia, Enrico","Rossi, Giorgio","Angrisani, Marco","Consonni, Dario","Fornoni, Gianluca","Piccolo, Giuseppe","DeFeo, Tullia Maria"],"date":"2020-04-25T11:00:00Z","year":2020,"_id":"32330351","week":"202017|Apr 20 - Apr 26","doi":"10.1111/ajt.15948","source":"PubMed","topics":["Prevention"],"weight":1,"locations":["Italy","Lombardy","Lombardy","Score"],"countries":["Italy"],"countries_codes":["ITA|Italy"],"_version_":1664996914790137857,"score":182.93181}]}